STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2995 by analyst upside · 2026-08-13
SRRK
Scholar Rock Holding Corporation
Healthcare · Market Cap $7B · P/E 0x
ANALYST PRICE TARGET
+11.4%
implied upside to consensus target
Current Price $53.82
Consensus Target $59.94
Bull Target $76.0
Bear Target $48.0
Analysts Covering 16
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
13
Hold
0
Sell
0
52-Week Low $27.07
52-Week High $58.49
YTD Return +25.7%
FUNDAMENTALS
Market Cap $7B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-3.31
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $27.07
52-Week High $58.49
Current Price $53.82
Bear Target $48.0
Bull Target $76.0
● Now $53.82 ● Target $59.94
TRADING DATA
Avg Volume 1.4M
YTD Return +25.7%
Analyst Count 16
Consensus Buy
Upside to Target +11.4%
Last Updated 2026-08-13

ANALYST SUMMARY

Scholar Rock Holding Corporation (SRRK) is currently trading at $53.82 with a Wall Street consensus price target of $59.94, implying potential upside of 11.4% over the next 12 months. 16 analysts currently cover SRRK, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $76.0, while the most cautious has a target of $48.0.

SRRK operates in the Healthcare sector with a market capitalisation of $7B. The stock is up 25.7% year-to-date and is currently trading near the upper end of its 52-week range of $27.07 – $58.49.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for SRRK, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays - Reiterated
Overweight → Overweight 2026-05-08 Building track record
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-05-08 31% win rate (48 calls)
Canaccord Genuity ● Initiated
Buy 2026-04-21 Building track record
Wedbush - Reiterated
Outperform → Outperform 2026-04-01 Building track record
JP Morgan - Reiterated
Overweight → Overweight 2026-03-16 43% win rate (7 calls)
Citigroup - Reiterated
Buy → Buy 2026-03-04 Building track record
BMO Capital - Reiterated
Outperform → Outperform 2026-03-04 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-03-04 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
69
out of 100
Coverage depth
22/30
Consensus clarity
20/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →